Calcium pyrophosphate deposition disease

钙 焦磷酸钙 沉积(地质) 化学 材料科学 地质学 冶金 沉积物 古生物学
作者
Tristan Pascart,Georgios Filippou,Frédéric Lioté,Silvia Sirotti,Charlotte Jauffret,Abhishek Abhishek
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:6 (11): e791-e804 被引量:64
标识
DOI:10.1016/s2665-9913(24)00122-x
摘要

Calcium pyrophosphate deposition (CPPD) disease is a consequence of the immune response to the pathological presence of calcium pyrophosphate (CPP) crystals inside joints, which causes acute or chronic inflammatory arthritis. CPPD is strongly associated with cartilage degradation and osteoarthritis, although the direction of causality is unclear. This clinical presentation is called CPPD with osteoarthritis. Although direct evidence is scarce, CPPD disease might be the most common cause of inflammatory arthritis in older people (aged >60 years). CPPD is caused by elevated extracellular-pyrophosphate concentrations in the cartilage and causes inflammation by activation of the NLRP3 inflammasome. Common risk factors for CPPD disease include ageing and previous joint injury. It is uncommonly associated with metabolic conditions (eg, hyperparathyroidism, haemochromatosis, hypomagnesaemia, and hypophosphatasia) and genetic variants (eg, in the ANKH and osteoprotegerin genes). Apart from the detection of CPP crystals in synovial fluid, imaging evidence of CPPD in joints by mainly conventional radiography, and increasingly ultrasonography, has a central role in the diagnosis of CPPD disease. CT is useful in showing calcification in axial joints such as in patients with crowned dens syndrome. To date, no treatment is effective in dissolving CPP crystals, which explains why control of inflammation is currently the main focus of therapeutic strategies. Prednisone might provide the best benefit-risk ratio for the treatment of acute CPP-crystal arthritis, but low-dose colchicine is also effective with a risk of mild diarrhoea. Limited evidence suggests that colchicine, low-dose weekly methotrexate, and hydroxychloroquine might be effective in the prophylaxis of recurrent flares and in the management of persistent CPP-crystal inflammatory arthritis. Additionally, biologics inhibiting IL-1 and IL-6 might have a role in the management of refractory disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
太清完成签到,获得积分10
刚刚
刚刚
刚刚
wswalnut完成签到 ,获得积分10
1秒前
zzw发布了新的文献求助10
1秒前
1秒前
2秒前
NexusExplorer的应助被啊pang采纳,获得10
3秒前
3秒前
3秒前
3秒前
偷酒的馒头猫完成签到,获得积分10
4秒前
三井寿完成签到,获得积分10
4秒前
科研通AI6.2的应助被皇后采纳,获得10
6秒前
斯文败类的应助被天天采纳,获得10
6秒前
6秒前
科研通AI2S的应助被Jessica采纳,获得10
7秒前
8秒前
歪歪完成签到 ,获得积分10
8秒前
8秒前
wswalnut关注了科研通微信公众号
9秒前
张小白的应助被gxhjky采纳,获得10
9秒前
董文强发布了新的文献求助10
9秒前
什么呀发布了新的文献求助10
10秒前
雾峰完成签到,获得积分10
10秒前
10秒前
慕青的应助被pump采纳,获得10
10秒前
11秒前
Mia123的应助被无知的h采纳,获得200
11秒前
linzhy完成签到,获得积分10
12秒前
随风完成签到,获得积分10
12秒前
li完成签到,获得积分10
12秒前
苏浩然发布了新的文献求助10
13秒前
13秒前
14秒前
15秒前
学术文献互助的应助被各方面采纳,获得200
15秒前
15秒前
ww发布了新的文献求助10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8156499
求助须知:如何正确求助?哪些是违规求助? 9552615
关于积分的说明 21710463
捐赠科研通 7745506
什么是DOI,文献DOI怎么找? 3426576
关于科研通互助平台的介绍 2551389
邀请新用户注册赠送积分活动 2470382